Skip to main content

Pharmakotherapie von Tumoren

  • Chapter
Pharmakotherapie

Part of the book series: Springer-Lehrbuch ((SLB))

  • 2797 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Weiterführende Literatur

  • Arteaga CL (2003) Inhibiting tyrosine kinases: success and limitations. Cancer Biol Ther 2(4 Suppl 1): S79–S83

    PubMed  CAS  Google Scholar 

  • Berger DP, Engelhardt R, Mertelsmann R (2002) Das Rote Buch, Hämatologie und Internistische Onkologie. Ecomed Verlag, Landsberg

    Google Scholar 

  • Blakey DC (2003) Anti-cancer drug discovery and development summit. Expert Opin Investig Drugs 12: 1577–1582

    Article  PubMed  CAS  Google Scholar 

  • Deutsche Gesellschaft für Hämatologie und Onkologie, www.dgho.de

    Google Scholar 

  • Nahta R, Esteva FJ (2003) HER-2 targeted therapy: lessons learned and future directions. Clin Cancer Ther 9: 5078–5084

    CAS  Google Scholar 

  • National Cancer Institute, USA, www.nci.nih.gov

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Fromm, M.F., Gramatzki, M. (2007). Pharmakotherapie von Tumoren. In: Lemmer, B., Brune, K. (eds) Pharmakotherapie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-34181-9_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-34181-9_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-34180-2

  • Online ISBN: 978-3-540-34181-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics